| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 441.595 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 467.901 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 351.17 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 464.249 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 414.767 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 368.066 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 398.095 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 556.864 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 574.602 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 447.737 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 528.907 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 537.437 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 437.096 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 458.845 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 473.664 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 505.093 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 451.901 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 500.791 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 608.308 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 596.994 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 438.435 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 665.307 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 484.379 | 91 |